[e-farmacos] WHO Pharmac Newsletter n 3, 2006

["Mariano y Martin" <e-farmacos@healthnet.org>]

Estimadas y estimados amigos,

Acaba de publicarse el numero 3 de 2006, del WHO Pharmaceuticals Newsletter:

La direccion del ejemplar en la WHO-Ginebra:
http://www.who.int/medicines/publications/newsletter/pn2006_3.pdf 

Contenido:

Regulatory Matters
-Acetylcysteine -- New paediatric dosing information?.. 1
-Anabolic steroids -- Not to be sold as dietary supplements . 1
-Denileukin diftitox -- Label to include reports of visual loss.. 1
-l-Arginine -- Not for heart patients . 1
-Pegaptanib sodium -- Reports of anaphylaxis/anaphylactoid reactions.. 2

Safety of Medicines
-Bowel cleansing oral sodium phosphates -- Risk of renal damage .. 3
-Glucosamine products -- 86 reports to date in Sweden..3
-Isotretinoin -- Suspected association with vascular disorders... 3
-Mifepristone -- Two additional sepsis deaths....3
-Miracle Bion -- Risk of E.coli contamination.... 4
-Pimecrolimus and tacrolimus -- Cautious use recommended.. 4
-Polygonum multiflorum -- Risk of liver effects.. 4
-Yohimbine-containing products -- Dangerous in high-risk groups .. 4

Feature
New Challenges in Safety of Medicines: highlights from the Twelfth International

Conference of Drug Regulatory Authorities .. 6

Saludos,

Martin y Mariano